|
|||
|
Research Interests include: non-alcoholic fatty liver disease and mitochondrial dysfunction, cyanoacrylates in variceal bleeding, ascites, coagulopathy in liver disease, liver assist devices, viral hepatitis, techniques in liver biopsy and alcoholic liver disease. Selected Publications: Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: A disease of older obese, diabetic females. Hepatology 1999;29:664-9. Falstrom JK, Goodman NC, Moore MM, Caldwell SH, Matsumoto AH, Abbott RD, Spotnitz WD. Use of fibrin sealant as a hemostatic plug for percutaneous liver biopsy tract. Journal Vascular and Invasive Radiol 1999;10:457-62. Caldwell S, Swerdlow R, Khan E, Iezzoni J, Hespenheide E, Oelsner D, Driscoll C, Parker W. Mitochondrial abnormalities in NASH. Journal of Hepatology 1999;31:430-34 Struben VMD, Hespenheide EE, Caldwell SH. Familial patterns of Non-alcoholic steatohepatitis (NASH) and cryptogenic cirrhosis. Am J Med 2000;;108:9-13 Caldwell SH, Peruggia M, Chen L, Angle JF, Patrie JT, Hespenheide EE, Struben VMD, de Lange EE. Relationship between liver and spleen size, the collateral system and the portosystemic gradient. (submitted). Shami V, Caldwell SH, Bickston SJ, Hespenheide EE, Macik G. Recombinant activated factor VII in fulminant liver failure. Liver Transplantation 2003;9:138-43. Caldwell SH, Hespenheide EE, von Borstel RW. Myositis, microvesicular hepatitis, and progression to cirrhosis from troglitazone added to simvastatin. Digestive Disease and Science 2001;46:376-8.Caldwell SH, Hespenheide EE, Redick JA, Iezzoni JC, Battle EH, Sheppard Bl. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis. Am J Gastroenterology 2001;96:519-25. Harris DM, Hespenheide EE, Dalkin AC, Kirk SE, Ellis D, Caldwell SH. Hyperthyroidism with interferon-ribavirin therapy for hepatitis C: A case report and Proposed Treatment Algorithm. Am J Gastroenterology 2000;95:2995-6. Caldwell SH, Harris DM, Patrie J, Hespenheide EE. Are NASH and cryptogenic cirrhosis under diagnosed African Americans? Am J Gastro 2002;97:1496-1500 Caldwell SH, Hespenheide EE. Subacute liver failure in obese females. Am J Gastro 2002;97:2058-62. Al-Osaimi A, Caldwell SH. Intermittent Disconjugate Gaze in NASH and Cryptogenic Cirrhosis. (in preparation) Caldwell SH, Le TH, Hespenheide EE. The lobular distribution of mitochondrial abnormalities in NASH. (in revisions) Greenwald BD, Caldwell SH, Hespenheide EE, Patrie JT, Williams J, Woodall L, Haluszka O. N-2-butyl cyanoacrylate for bleeding gastric varices: A US pilot study and cost analysis. Am J Gastro 2003;accepted. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: Summary of an AASLD single topic conference. Hepatology 2003;37:1202-19. |
